Release Date: 04/15/2015Mai (Mike) He, MD PhD, medical director of the Hematology Laboratory at Women & Infants Hospital of Rhode Island and assistant professor of perinatal pathology at The Warren Alpert Medical School of Brown University, Yun-An (Ann) Tseng, DO, the Stuart C. Lauchlan Fellow in Women’s Pathology at Women & Infants Hospital, were honored at the 2015 United States and Canadian Academy of Pathology (USCAP) Annual Meeting in March.
Dr. He won the Enid Gilbert Barness prize for his study, “Comparison of placental findings in type 1 and type 2 diabetic pregnancies.” Dr. He earned his undergraduate and medical school degrees at Shanghai Medical College of Fudan University and doctorate degree at University Medicine and Dentistry of New Jersey (Rutgers University). He completed his residency in anatomic and clinical pathology at University Hospital in Newark, NJ and completed three fellowships in postdoctoral surgical oncology research at New Jersey Medical School, pediatric pathology at Coney Island Hospital/Downstate Medical Center, and diagnostic molecular pathology at Memorial Sloan-Kettering Cancer Center. Dr. He is board certified in anatomic and clinical pathology, pediatric pathology and molecular genetic pathology.
Dr. Tseng won the Surgical Pathology Award for her poster presentation, “Endometrial Surface Epithelial Change (ESEC) in Endometrial Samplings: A Banal Appearing Histologic Marker of Underlying Endometrioid Adenocarcinoma in Postmenopausal Women.” Out of 3,100 abstracts in surgical pathology-related disciplines, Dr. Tseng’s presentation received first place in the competition for the award. Dr. Tseng earned her undergraduate degree in chemistry at Rutgers University. After completing medical school at New York College of Osteopathic Medicine, Dr. Tseng went on to complete a pathology residency at Winthrop University Hospital in Mineola, NY and is now nearing the end of the Stuart C. Lauchlan Fellowship in Women’s Pathology at Women & Infants. She is board certified in anatomic pathology.
The 104th USCAP annual meeting was attended by more than 5,000 pathology professionals from around the world, with attendees coming from 87 countries as well as those in North America.
“We are thrilled by the national and international recognition afforded to our department by these two coveted awards,” said W. Dwayne Lawrence, MD, MSc (Path.), Chief of Pathology and Laboratory Medicine at Women & Infants Hospital and Executive Chief of the Department of Pathology and Laboratory Medicine at the Care New England. “Indeed, they represent the culmination of a great deal of hard work and creative energy by our Divisions of Perinatal and Pediatric Pathology and Gynecologic and Breast Pathology.”
About the United States and Canadian Academy of Pathology (USCAP)
For more than 100 years, the USCAP has been the global leader for advancing knowledge in the field of pathology. The USCAP mission is to provide pathologists with high quality information at the investigative and applied practice level to reinforce and update their knowledge of pathology in their unique area of interest.
About Women & Infants Hospital
Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility. It is home to the nation’s first mother-baby perinatal psychiatric partial hospital, as well as the nation’s only fellowship program in obstetric medicine.
Women & Infants has been designated as a Breast Imaging Center of Excellence by the American College of Radiography; a Center of Excellence in Minimally Invasive Gynecology; a Center of Biomedical Research Excellence by the National Institutes of Health (NIH); and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute’s Gynecologic Oncology Group and the Pelvic Floor Disorders Network.